Insulin glulisine: a new rapid‐acting insulin analogue
Authors
Abstract
Insulin glulisine is the latest rapid‐acting insulin analogue to become available. Here Dr Narendran describes the results of clinical trials of its efficacy and tolerability, and considers its potential role in the management of diabetes. Copyright © 2006 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.400 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
